Regeneron Pharmaceuticals (NQ: REGN )
1,063.60
-3.66
(-0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals![]()
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron
November 17, 2022
Via Benzinga
Regeneron Pharmaceuticals's Return On Capital Employed Overview
November 17, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|